Design and baseline characteristics of the Soy Phytoestrogens As Replacement Estrogen (SPARE) study - A clinical trial of the effects of soy isoflavones in menopausal women

Contemporary Clinical Trials

Volumn 31, Issue 4, 2010, Pages 293-302

  Levis, Silvina ^a   Strickman Stein, Nancy ^a   Doerge, Daniel R ^b   Krischer, Jeffrey ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Bone health; Isoflavones; Menopause; Osteoporosis; Soy

Indexed keywords

CALCIUM CARBONATE; ESTRADIOL; ISOFLAVONE DERIVATIVE; LIPID; PHYTOESTROGEN; PLACEBO; SOY ISOFLAVONE; THYROTROPIN; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HIP; HISPANIC; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MEASUREMENT; MENOPAUSE; MOOD CHANGE; MORNING DOSAGE; OSTEOLYSIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPINE; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; URINALYSIS;

ANALYSIS OF VARIANCE; BONE DENSITY; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; ISOFLAVONES; LOGISTIC MODELS; LUMBAR VERTEBRAE; MENOPAUSE; MIDDLE AGED; PATIENT SELECTION; PHYTOESTROGENS; SOYBEANS; VAGINA;

EID: 77953544142     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2010.03.007     Document Type: Article

References (57)

1. Utian W.H. The place of oestriol therapy after menopause. Acta Endocrinol Suppl (Copenh) 233 (1980) 51-56
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288 (2002) 321-323
3. Buist D.S., Newton K.M., Miglioretti D.L., et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 104 (2004) 1042-1050
4. Newton K.M., Buist D.S., Hartsfield C.L., et al. Hormone therapy initiation after the Women's Health Initiative. Menopause 15 (2009) 487-493
5. Wei F., Miglioretti D.L., Connelly M.T., et al. Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr 35 (2005) 106-112
6. Kupferer E.M., Dormire S.L., and Becker H. Complementary and alternative medicine use for vasomotor symptoms among women who have discontinued hormone therapy. J Obstet Gynecol Neonatal Nurs 38 (2009) 50-59
7. Ma D.F., Qin L.Q., Wang P.Y., and Katoh R. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr 27 (2008) 57-64
8. Liu J., Ho S.C., Su Y.X., Chen W.Q., Zhang C.X., and Chen Y.M. Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials. Bone 44 (2009) 948-953
9. Uesugi T., Fukui Y., and Yamori Y. Beneficial effects of soybean isoflavone supplementation on bone mineral metabolism and serum lipid in postmenopausal Japanese women: a four-week study. J Am Coll Nutr 21 (2002) 97-102
10. Gallagher J.C., Satpathy R., Rafferty K., and Haynatzka V. The effect of soy protein isolate on bone metabolism. Menopause 11 (2004) 290-298
11. Potter S.M., Baum J.A., Teng H., et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68 6 Suppl (1998) 1375S-1379S
12. Morabito N., Crisafulli A., Vergara C., et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17 (2002) 1904-1912
13. Yamori Y., Moriguchi E.H., Teramoto T., et al. Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil: a ten-week study. J Am Coll Nutr 21 (2002) 560-563
14. Harkness L.S., Fiedler K., Sehgal A.R., et al. Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. J Women's Health 13 (2004) 1000-1007
15. Wangen K.E., Duncan A.M., Mertz-Demlow B.E., et al. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 85 (2000) 3043-3048
16. Lydeking-Olsen E., Beck-Jensen J.E., Setchell K.D., and Holm-Jensen T. Soymilk or progesterone for prevention of bone loss - a 2-year randomized, placebo-controlled trial. Eur J Nutr 43 (2005) 246-257
17. Bunout D., Barrera G., Leiva L., et al. Effect of a nutritional supplementation on bone health in Chilean elderly subjects with femoral osteoporosis. J Am Coll Nutr 25 (2006) 170-177
18. Kenny A.M., Mangano K.M., Abourizk R.H., et al. Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial. Am J Clin Nutr 90 (2009) 234-242
19. Chiechi L.M., Secreto G., D'Amore M., et al. Efficacy of soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas 42 (2002) 295-300
20. Brink E., Coxam V., Robins S., Wahala K., Cassidy A., Branca F., and PHYTOS Investigators. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr 87 (2008) 761-770
21. Vupadhyayula P.M., Gallagher J.C., Templin T., Logsdon S.M., and Smith L.M. Effects of soy protein isolate on bone mineral density and physical performance indices in postmenopausal women - a 2-year randomized, double-blind, placebo-controlled trial. Menopause 16 (2009) 320-328
22. Wu J., Oka J., Higuchi M., et al. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metabolism 55 (2006) 423-433
23. Kreijkemp-Kaspers S., Kok L., Grobbee D.E., et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292 (2004) 65-74
24. Marini H., Minutoli L., Polito F., et al. Effects of phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women. Ann Int Med 146 (2007) 839-847
25. Wong W.W., Lewis R.D., Steinberg F.M., Murray M.J., Cramer M.A., and Amato P. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial. Am J Clin Nutr 90 (2009) 1433-1439
26. Alekel L.D., Van Loan M.D., Koehler K.J., et al. The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women. Am J Clin Nutr 91 (2010) 218-230
27. Adlercreutz H., Markhanen H., and Watanabe S. Plasma concentration of phyto-oestrogens in Japanese men. Lancet 342 (1993) 1209-1210
28. Doerge D.R., and Chang H.C. Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo. J Chromatogr B Biomed Appl J Chrom B 777 (2002) 245-255
29. Block G. Dietary assessment issues related to cancer for NHANES III. Vital Health Stat 4 (1992) 24-31
30. Perczek R.E., Carver C.S., Price A.A., and Pozo-Kaderman C. Coping, mood, and aspects of personality in Spanish translation and evidence of convergence with English versions. J Pers Assess 74 (2000) 63-87
31. Eastell R., Mallinak N., Weiss S., et al. Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women. J Bone Miner Res 15 (2000) 594-598
32. Greendale G.A., Zibecchi L., Petersen L., Ouslander J.G., Kahn B., and Ganz P.A. Development and validation of a physical examination scale to assess vaginal atrophy and inflammation. Climacteric 2 (1999) 197-204
33. Meisels A. The maturation value. Acta Cytol 11 (1967) 249
34. Doerge D.R., Chang H.C., Holder C.L., and Churchwell M.I. Enzymatic conjugation of the soy isoflavones, genistein and daidzein, and analysis in human blood using liquid chromatography and mass spectrometry. Drug Metab Dispos 28 (2000) 298-307
35. Dipietro L., Caspersen C.J., Ostfeld A.M., and Nadel E.R. A survey for assessing physical activity among older adults. Med Sci Sports Exerc 25 (1993) 628-642
36. Wilkund I., Holst J., Karlberg J., et al. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas 14 (1992) 211-224
37. Ware J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). Med Care 30 (1992) 473-483
38. Beck A.T., Steer R.A., and Garrison R. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8 (1988) 77-100
39. McNair DM, Lorr M, Droppleman LF. Profile of mood of states (POMS) manual. San Diego, CA: Educational and Industrial Testing Service, 1071.
40. Recker R.R., Davies K.M., Dowd K., and Heaney R. Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 15 (2000) 1965-1973
41. Kardinaal A.F., Morton M.S., Brüggemann-Rotgans I.E., and van Beresteijn E.C. Phyto-oestrogen excretion and rate of bone loss in postmenopausal women. Eur J Clin Nutr 52 (1998) 850-855
42. Cummings S.R., and Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 359 (2002) 1761-1767
43. Finkelstein J.S., Brockwell S.E., Mehta V., et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab 93 (2008) 861-868
44. Ahlborg H.G., Johnell O., Nilsson B.E., Jeppsson S., Rannevik G., and Karlsson M.K. Bone loss in relation to menopause: a prospective study during 16 years. Bone 28 (2001) 327-331
45. Sowers M.R., Jannausch M., McConnell D., et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 91 (2006) 1261-1267
46. Rossouw J.E., Anderson G.L., Prentice R.L., et al., Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
47. Vincent A., and Fitzpatrick L.A. Soy isoflavones: are they useful in menopause?. Mayo Clin Proc 75 (2000) 1174-1184
48. Joannou G.E., Kelly G.E., Reeder A.Y., Waring M., and Nelson C. A urinary profile study of dietary phytoestrogens: the identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol 54 (1995) 167-184
49. Fang H., Tong W., Shi L.M., et al. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol 14 (2001) 280-295
50. Kuiper G.G., Lemmen J.G., Carlsson B., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
51. Poulsen R.C., and Kruger M.C. Soy phytoestrogens: impact on postmenopausal bone loss and mechanism of action. Nutr Rev 66 (2008) 359-374
52. Yamagishi T., Otsuka E., and Hagiwara H. Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis. Endocrinology 142 (2001) 3632-3637
53. Chen X.W., Garner S.C., and Anderson J.J. Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. Biochem Biophys Res Commun 295 (2002) 417-422
54. Mei C., Yeung S.S.C., and Kung A.W.C. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86 (2001) 5217-5221
55. Zhang X., Shu X.O., Li H., et al. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Int Med 165 (2005) 1890-1895
56. Horiuchi T., Onouchi T., Takahashi M., Ito H., and Orimi H. Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 11 (2000) 721-724
57. Kritz-Silverstein D., and Goodman-Gruen D.L. Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women. J Womens Health Gend Based Med 11 (2002) 69-78